Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data

The article reports a week of mixed momentum in healthcare, citing multiple U.S. FDA and European Commission approvals alongside strategic licensing, clinical trial readouts, and some regulatory setbacks. It does not provide specific approval/ trial outcomes or deal sizes, limiting clear read-through to earnings or pricing power.